Sinibaldi-Vallebona P - Search Results

1

Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.

Matteucci C, Minutolo A, Sinibaldi-Vallebona P, Palamara AT, Rasi G, Mastino A, Garaci E. Matteucci C, et al. Ann N Y Acad Sci. 2010 Apr;1194:6-19. doi: 10.1111/j.1749-6632.2010.05484.x. Ann N Y Acad Sci. 2010. PMID: 20536445 Review.

2

Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats.

Rasi G, Silecchia G, Sinibaldi-Vallebona P, Spaziani E, Pierimarchi P, Sivilia M, Tremiterra S, Garaci E. Rasi G, et al. Int J Cancer. 1994 Jun 1;57(5):701-5. doi: 10.1002/ijc.2910570516. Int J Cancer. 1994. PMID: 8194879

3

Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B.

Rasi G, Mutchnick MG, Di Virgilio D, Sinibaldi-Vallebona P, Pierimarchi P, Colella F, Favalli C, Garaci E. Rasi G, et al. J Viral Hepat. 1996 Jul;3(4):191-6. doi: 10.1111/j.1365-2893.1996.tb00094.x. J Viral Hepat. 1996. PMID: 8871880 Clinical Trial.

4

Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.

Rasi G, DiVirgilio D, Mutchnick MG, Colella F, Sinibaldi-Vallebona P, Pierimarchi P, Valli B, Garaci E. Rasi G, et al. Gut. 1996 Nov;39(5):679-83. doi: 10.1136/gut.39.5.679. Gut. 1996. PMID: 9026482 Free PMC article.

5

Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms.

Serafino A, Sinibaldi-Vallebona P, Gaudiano G, Koch TH, Rasi G, Garaci E, Ravagnan G. Serafino A, et al. Anticancer Res. 1998 Mar-Apr;18(2A):1159-66. Anticancer Res. 1998. PMID: 9615782

6

Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis.

Guadagni F, Graziano P, Roselli M, Mariotti S, Bernard P, Sinibaldi-Vallebona P, Rasi G, Garaci E. Guadagni F, et al. Am J Pathol. 1999 Apr;154(4):993-9. doi: 10.1016/S0002-9440(10)65351-5. Am J Pathol. 1999. PMID: 10233837 Free PMC article.

7

Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery.

Silecchia G, Guarino E, Sinibaldi-Vallebona P, Pierimarchi P, Restuccia A, Spaziani E, Bernard P, Tuthill C, Garaci E, Rasi G. Silecchia G, et al. Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562. Cancer Immunol Immunother. 1999. PMID: 10431686 Free PMC article.

8

Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?

Serafino A, Sinibaldi-Vallebona P, Pierimarchi P, Bernard P, Gaudiano G, Massa C, Rasi G, Ranagnan G. Serafino A, et al. Anticancer Res. 1999 May-Jun;19(3A):1909-18. Anticancer Res. 1999. PMID: 10470135

9

A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells.

Rasi G, Sinibaldi-Vallebona P, Serafino A, Bernard P, Pierimarchi P, Guarino E, Faticanti-Scucchi L, Graziano P, Guadagni F, Garci E. Rasi G, et al. Int J Cancer. 2000 Feb 15;85(4):540-4. doi: 10.1002/(sici)1097-0215(20000215)85:4<540::aid-ijc16>3.0.co;2-v. Int J Cancer. 2000. PMID: 10699928

10

Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma.

Rasi G, Terzoli E, Izzo F, Pierimarchi P, Ranuzzi M, Sinibaldi-Vallebona P, Tuthill C, Garaci E. Rasi G, et al. Melanoma Res. 2000 Apr;10(2):189-92. Melanoma Res. 2000. PMID: 10803720 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters